亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Are There Upper Limits in Tumor Burden for Down‐Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All‐Comers Protocol

肝细胞癌 医学 米兰标准 危险系数 肝移植 内科学 胃肠病学 肝癌 外科 移植 置信区间
作者
Jasmine Sinha,Neil Mehta,Jennifer L. Dodge,Eduard Poltavskiy,John P. Roberts,Francis Y. Yao
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:70 (4): 1185-1196 被引量:67
标识
DOI:10.1002/hep.30570
摘要

Patients with hepatocellular carcinoma (HCC) within the University of California, San Francisco down‐staging (UCSF‐DS) criteria (one lesion > 5 cm and ≤ 8 cm; two to three lesions each ≤ 5 cm; or four to five lesions each ≤ 3 cm with total tumor diameter ≤ 8 cm) who achieved successful down‐staging (DS) to Milan criteria had similar outcomes after liver transplantation (LT) compared with HCC initially meeting the Milan criteria. Nevertheless, little is known about the outcome of DS in patients with initial tumor burden exceeding the UCSF‐DS criteria, defined as “all‐comers” (AC). We compared the intention‐to‐treat (ITT) outcomes of DS in 74 patients in the AC group and 133 patients in the UCSF‐DS group. Successful DS to Milan was observed in 64.8% of the AC group versus 84.2% of the UCSF‐DS group ( P < 0.001). The sum of tumor number and largest tumor diameter was significantly associated with successful DS (hazard ratio [HR] 0.87, P < 0.05). The cumulative probability of dropout within 1 year and 3 years was 53.5% and 80.0%, respectively, for AC versus 25.0% and 36.1%, respectively, for UCSF‐DS ( P < 0.0001). Factors predicting dropout included sum of tumor number and largest tumor diameter greater than 8 (HR 1.79, P = 0.049) and Child class B and C (HR 2.54, P = 0.001). The AC group also had a significantly lower liver transplant (LT) rate (13.5% versus 59.0%, P < 0.001). ITT survival at 1 year and 5 years was 77.4% and 21.1%, respectively, in AC versus 85.5% and 56.0%, respectively, in UCSF‐DS ( P < 0.001). Three of 10 patients in the AC group who underwent LT developed HCC recurrence. Conclusion: We observed a significantly lower LT probability and inferior ITT survival with DS in the AC group versus the UCSF‐DS group. Our results suggest that an upper limit in tumor burden exists beyond which successful LT after DS becomes an unrealistic goal.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
13秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
Ma发布了新的文献求助10
23秒前
23秒前
科研通AI5应助Ma采纳,获得10
44秒前
忧伤的绍辉完成签到 ,获得积分10
45秒前
隐形曼青应助易四夕采纳,获得10
49秒前
1分钟前
易四夕发布了新的文献求助10
1分钟前
1分钟前
1分钟前
Ma发布了新的文献求助10
2分钟前
2分钟前
随机子发布了新的文献求助10
2分钟前
2分钟前
Ava应助科研通管家采纳,获得10
2分钟前
科目三应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
Ma发布了新的文献求助10
2分钟前
Ma完成签到,获得积分10
3分钟前
3分钟前
易四夕发布了新的文献求助10
3分钟前
4分钟前
4分钟前
英姑应助王大壮采纳,获得10
4分钟前
SciGPT应助科研通管家采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
Mine发布了新的文献求助10
4分钟前
王大壮发布了新的文献求助10
4分钟前
Mine完成签到,获得积分10
4分钟前
郗妫完成签到,获得积分10
5分钟前
王大壮发布了新的文献求助10
5分钟前
科研通AI5应助Mine采纳,获得30
5分钟前
5分钟前
852应助美好颜采纳,获得10
5分钟前
纯情女大完成签到 ,获得积分10
5分钟前
5分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968492
求助须知:如何正确求助?哪些是违规求助? 3513278
关于积分的说明 11167214
捐赠科研通 3248660
什么是DOI,文献DOI怎么找? 1794386
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804638